Jakavi (ruxolitinib) 20 mg film-coated tablets, 56 tablets — original (Novartis, Switzerland) Treatment of diseases associated with splenomegaly or symptoms of primary myelofibrosis Targeted cancer therapy. Drug delivery from Europe. +380996042415 Viber, WhatsApp
Delivery methods
- EMC post
Delivery time
- 7-10 days
Payment methods
- Payment to Revolut card
Indications
- Treatment of diseases associated with splenomegaly or symptoms of primary myelofibrosis (also known as chronic idiopathic myelofibrosis) in adult patients, myelofibrosis due to polycythemia vera, or myelofibrosis due to essential thrombocythemia.
- Trade Name:Jakavi
- Chemical Name:Ruxolitinib
- Dosage:15 mg
- Quantity:56
- Form of Issue:Tablets
No reviews yet
